4,5-dianilinophthalimide,
CGP 52411,
CGP 53353,
CGP 54211,
CGP-52411,
CGP53353,
DAPH1,
145915-60-2,
CGP 53353,
CGP-53353,
DAPH 2,
DAPH-7,
CGP53353,
PKCbetaII/EGFR Inhibitor,
5,6-BIS[(4-FLUOROPHENYL)AMINO]-1H-ISOINDOLE-1,3(2H)-DIONE,
CHEMBL7939,
5,6-Bis((4-fluorophenyl)amino)isoindoline-1,3-dione,
4,5-bis(4-Fluoroanilino)-phthalimide,
CGP 53 353,
CG53353,
5,6-Bis[(4-fluorophenyl)amino]-2H-isoindole-1,3-dione,
4,5-Bis(4-fluoroanilino)phthalimide,
4,5-Bis[4-fluoroanilino]phthalimide,
1H-Isoindole-1,3(2H)-dione, 5,6-bis((4-fluorophenyl)amino)-,
1H-Isoindole-1,3(2H)-dione, 5,6-bis[(4-fluorophenyl)amino]-,
PKCbII/EGFR Inhibitor,
AC1O8KXF,
5,6-bis(4-fluoroanilino)isoindole-1,3-dione,
CGP-53353, solid,
DAPH-2,
MolMap_000016,
SCHEMBL230492,
GTPL5163,
CHEBI:92560,
CTK8E9235,
RONQPWQYDRPRGG-UHFFFAOYSA-N,
HMS3229K07,
HMS3269E05,
HMS3677M18,
ZINC600430,
BDBM50040930,
BS0228,
IN1137,
MFCD00938569,
AKOS015911570,
CCG-206784,
NCGC00159569-01,
NCGC00159569-02,
CC-20902,
ZB014534,
DB-042814,
RT-012226,
B7056,
FT-0643387,
C-35653,
5,6-bis(4-fluorophenylamino)isoindoline-1,3-dione,
J-008169,
5,6-Bis-(4-fluoro-phenylamino)-isoindole-1,3-dione,
BRD-K32292990-001-01-0,
I14-37922,
5,6-bis[(4-fluorophenyl)amino]-2,3-dihydro-1H-isoindole-1,3-dione,
D0HO1S,
CID6711154,